4,901 trials
Healthy
Primary: Area Under the Concentration-time Curve of BI 1584862 in Plasma Over the Time Interval From 0 Extrapolated to Infinity (AUC0-∞) — 999.27; 7981.53 hour*nanomole/Liter
Healthy
Primary: Mass Balance Recovery of Total Radioactivity in Urine and Faeces: Amount Excreted Within the Time Interval From 0 to the Time of the Last Quantifiable Data Point as a…
Gaucher Disease, Type 1
Primary: Number of Participants With Treatment-emergent Adverse Events Over Time — 6; 6; 6; 2 Participants
Obesity · Diabetes Mellitus, Type 2
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) — 1; 2; 3; 4 Participants
Eosinophilic Esophagitis
Primary: Ratio of AUC0-Inf for AQ280 Capsule vs Oral Suspension — 0.976 Ratio of AUC0-Inf for AQ280 Cap vs Tab
Healthy
Primary: Cmax of Aramchol — 3.334; 2.057; 0.668 µg/mL
HIV Infections
Primary: Part 1 Injection 1: Time of Maximum Observed Plasma Concentration (Tmax) for CAB 400 mg/ml Formulation for Cohorts 1,2,3,4, 4b & 4h — 197.731; 150.215; 122.009; 145.648…
Healthy
Primary: Part A: PK: Maximum Observed Concentration (Cmax) of LY3502970 Following Multiple Oral Doses of Prototype Formulations Compared to the Reference Formulation — 66.2; 111…
Hepatic Insufficiency · Hepatic Impairment
Primary: Area Under the Concentration Versus Time Curve From Time 0 to Infinity (AUC0-inf) of Enlicitide — 540; 559 nM·hr
Healthy
Primary: Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) From Time Zero to Infinity AUC(0-∞) of LY3502970 — 380; 1380 nanogram*hour per milliliter…
Healthy · Hepatic Insufficiency
Primary: Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve From Time Zero to Infinity (AUC [0-∞]) of LY3502970 — 130; 132; 209; 611 nanogram *hour per…
Healthy
Primary: Pharmacokinetics (PK): Maximum Observed Concentration (Cmax) of LY3502970 in Formulation 1 and Formulation 2 — 86.5; 86.5 nanogram per milliliter (ng/mL)
Healthy
Primary: Pharmacokinetics (PK): Absolute Bioavailability of LY3502970 — 77 Percentage
Healthy Volunteers
Primary: Incidence of Abnormal Physical Exam Findings — 0; 0; 0 Participants
Healthy
Primary: Feces Excretion of LY3502970 Radioactivity Over Time Expressed as a Percentage of the Total Radioactive Dose Administered — 86.75 percentage of the total radioactive dose